Hypogonadism - 29 Studies Found Completed : Open-Label Study, Evaluating Patient Satisfaction and Symptom Improvement When Treating Male Hypogonadism With Natesto™ : Hypogonadism : 2016-10-17 : Drug: NATESTO Testosterone Nasal Gel Participants will be Completed : Subcutaneous Testosterone Enanthate Safety in Adult Men Diagnosed With Hypogonadism (STEADY) : Hypogonadism : 2015-07-20 : Drug: Testosterone enanthate auto-injector Dose Adjustment 100 mg / 75 mg / 50 mg Completed : Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism : Hypogonadism : 2014-06-06 : Drug: Testosterone enanthate auto-injector Dose Adjustment 100 mg / 75 mg / 50 mg Completed : A Preliminary Clinical Study to Evaluate Fispemifene in the Treatment of Hypogonadism : Hypogonadism : 2006-02-09 : Drug: Fispemifene once daily for 4 weeks Completed : Testosterone Replacement Therapy Decreases Plasma Paraoxonase 1 Enzyme Activity In Male Patients With Hypogonadism : Hypogonadism : 2010-04-19 : Drug: Sustanon 250 mg/21 days Other Name: no name Completed : A Study Using Recombinant Human Luteinizing Hormone (r-hLH, Luveris®) in the Treatment of Chinese Women With Hypogonadotropic Hypogonadism : Hypogonadism : 2010-03-04 : Drug: Recombinant human luteinizing hormone (r-hLH) Withdrawn : Nebido Versus Placebo in Elderly Men With Typical Symptoms of Late Onset Hypogonadism Over a Period of 54 Weeks : Hypogonadism : 2008-07-02 : Drug: NEBIDO Patients will rec Completed : Oral Testosterone for the Treatment of Hypogonadism : Hypogonadism : 2012-10-25 : Drug: TSX-002 TSX-002 are capsules with testosterone as the active ingredient. Completed : Study to Evaluate the Safety and Efficacy of Androxal Treatment in Men With Secondary Hypogonadism : Secondary Hypogonadism : 2010-02-10 : Drug: Androxal 12.5 mg once da Completed : Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotrophic Hypogonadism : Hypogonadotropic Hypogonadism : 2016-03-17 : Drug: BGS649 Capsules will be Next >>>
